Neuroverse's C.E.O., Dr. Gil-da-Costa holds B.S. and M.S. degrees in Biology, and a Ph.D. in Cognitive Neurosciences - Biomedical Sciences. For the last 19 years, his pursuit of how the mind and brain work led him to behavioral field studies in Africa and Central America and neurophysiology laboratory research from Harvard University to the National Institutes of Health, where for 5 years he held a double affiliation at the National Institute of Mental Health and the National Institute on Deafness and Other Communication Disorders. His research has been distinguished with multiple awards, such as the Donald B. Lindsley Prize for Behavioral Neuroscience, featured in Nature Neuroscience and selected for the Society for Neuroscience 2012 Hot Topics List. Altogether, his research has contributed seminal findings on the evolutionary and neural foundations of human cognition and language, which are now incorporated in neurosciences reference textbooks and university curriculae. In the last 10 years, Dr. Gil-da-Costa's work has focused on translational research, developing novel brain imaging methods and brain-machine interfaces. First at the Salk Institute for Biological Studies, where these endeavors led to the development of several US patents and to co-founding Neuroverse. Dr. Gil-da-Costa is a reviewer for a wide variety of scientific journals and a science advisor for the Science and Entertainment Exchange, a program of the National Academy of Sciences, and for the National Academies Keck Future Initiatives, participating in the authorship of the interdisciplinary research team report on brain-computer interfaces, integrated in the volume "The Informed Brain in a Digital World".

Our team combined expertise in neurophysiology, cognitive psychology, mental health, mental performance, neuroergonomics, advanced analytical methods & bio and electrical engineering has enabled Neuroverse to develop a unique brain interface capable of serious neurocognitive assessments and neurofeedback, in a wearable intuitive form factor.

This multidisciplinary technical expertise paired with passionate and disciplined product development and financial execution led to the creation of an exciting and ever-growing system for mental performance, mental health and a variety of neurocognitive applications.

C.E.O.  Harvard University Nat. Institutes of Health Salk Institute
Ricardo GIL-DA-COSTA, Ph.D.
Harvard University
National Institutes of Health
Salk Institute for Biological Studies
Neuroergonomics Lead  UCSD Old Dominion University NASA Langley
Marla ZINNI, Ph.D.
Neuroergonomics Lead
U.C. San Diego
Old Dominion University
NASA Langley
Advanced Analytics Lead  UCSD
Advanced Analytics Lead
U.C. San Diego
Operations & Mfg. Lead
University of Melbourne
Catapult Sports
Outerspace Design
Engineering Lead  UCSD Northwestern University Kettering University
Michael BAJEMA, M.Sci.
Engineering Lead
Northwestern University
Kettering University
Operations Lead  Harvard University Nat. Institutes of Health Salk Institute
Marco LOPES, M.Sci.
Software Dev. Lead
Harvard University
National Institutes of Health
Salk Institute for Biological Studies
Office & Lab Manager  UCSD
Melissa CASWELL, B.Sci.
Office & Lab Manager
U.C. San Diego
Business Dev. Lead
Georgetown University
Nat. Institutes of Health
ABG; BNP Paribas

Advisory Board


Shu ChieN

Dr. Chien is a leading pioneer in the field of Bioengineering. Founding chair of the UCSD Dept. of Bioengineering and the founding Director of the UCSD Institute of Engineering and Medicine. Recipient of the National Medal of Science and Member of the National Academy of Engineering, National Academy of Sciences and Institute of Medicine, and the American Academy of Arts and Sciences.


Jean-Pierre Changeux

Dr. Changeux is the Director of the laboratory of Molecular Neurobiology at the Institut Pasteur in Paris. He has contributed landmark discoveries on the molecular and cellular mechanisms of signal recognition and transduction, and is a member of the Académie des Sciences, Paris, the US National Academy of Sciences and Institute of Medicine, the American Academy of Arts and Sciences and the Royal Academy of Sciences of Sweden.


Deepak Chopra

Dr. Chopra is Neuroverse’s Chief Advisor for the Public Understanding of MindBody Wellbeing. He is the founder of The Chopra Foundation and the Chopra Center for Wellbeing, is a world-renowned pioneer in mind-body medicine and personal transformation, and is Board Certified in Internal Medicine, Endocrinology and Metabolism.  He is a Fellow of the American College of Physicians and a member of the American Association of Clinical Endocrinologists.
He has authored more than 80 books, published in more than 43 languages, including 22 New York Times best sellers, two of them recognized on The Books of The Century Bestsellers List. For the last three years, recognizes Dr. Chopra as one of “The 100 Most Influential People in Health and Fitness “.  The World Post and The Huffington Post global internet survey ranked him #17 influential thinker in the world and #1 in Medicine Fitness. TIME magazine has described Dr. Chopra as “one of the top 100 heroes and icons of the century”. He serves as the Co founder of Jiyo, Founder of The Chopra Well on YouTube, as a Professors in various top universities, including, Columbia, UCSD and Northwestern universities, and as Faculty at Walt Disney Imagineering, and Senior Scientist with The Gallup Organization.


François Ferré

Dr. Ferré is the co-founder and co-CEO of ALMA Life Sciences LLC, a healthcare investment and consulting firm with a portfolio of over twenty private investments with a major focus on disease prevention. Dr. Ferré co-founded Althea Technologies and served as co-CEO from 1998 until 2008 and he is now a Director of Althea following its acquisition by Ajinomoto. He is also co-Founder of AltheaDx, a precision medicine company. He currently serves on the board of a number of private companies including Biomatrica and Portable Genomics. He is co-Chairman of the Advisory Board of MD Revolution. He serves as a Director of the La Jolla Institute and of the Chopra Foundation.  Dr. Ferré is a leader in genomics and has published several authoritative reviews in this field, including the co-edition of a bestseller book on PCR with Nobel Prize winner, Dr. Kary Mullis. He received his PhD in molecular oncology from the Pasteur Institute, France, and did his post-doctoral training at the University of California, San Diego. Dr. Ferré was the winner of the 2005 E&Y Regional Entrepreneur of the Year Award in the Life Sciences category. In 2016, Dr. Ferré was inducted into the CONNECT Entrepreneur Hall of Fame.


Isabel Pavão-Martins

Dr. Pavão-Martins is the Director of the Language Research Laboratory at Faculty of Medicine, University of Lisbon. She has over 20 years of both clinical and research experience on the fields of neural processing of language and migraine, with scientific publications on both subjects, and held previous positions at the National Hospital for Nervous Diseases, London, UK, and at the Dept. Neurology, The Hospitals for Sick Children, London, UK.


Gregory Light

Dr. Light is an Assistant Professor in the UCSD Department of Psychiatry, the Associate Director of the UCSD Schizophrenia Research Program, and of the Clinical Neuroscience Unit of the VISN-22 Mental Illness Research, Education, and Clinical Center (MIRECC). Dr. Light is a Clinical Psychologist with a specialization in Neuropsychology. His work has been seminal in the use of biological markers in neuropsychiatric disorders.


Gari Cheever

Mr. Cheever is a founding partner of Gunderson Dettmer's San Diego and Los Angeles offices. He has extensive experience developing, managing, and representing emerging growth companies, public corporations, venture capital and private equity firms. He spent two decades in Silicon Valley, where he represented numerous technology companies-from start-ups to Fortune 100 enterprises, including Cisco Systems, from its early days, through venture financing and IPO.

Julia Brown

Julia Brown

Julia R. Brown, an executive from the life science industry, is a member of the Board of Directors of Targacept, Inc., Labopharm, Inc., and MediQuest Therapeutics, Inc. and of the National Association of Corporate Directors. From 2000-2003 was Executive Vice President of Amylin Pharmaceuticals, Inc. and served as Advisor to the CEO until 2008. She is a member of the board of CONNECT, from which she received the award for "Distinguished Contribution to the Life Science Industry".


Magda Marquet

Dr. Marquet is a life sciences entrepreneur, investor and community leader. She is the co-founder and co-CEO of ALMA Life Sciences LLC, an investment and consulting firm with a focus on prevention. She is also the chairman and co-founder of Althea, and served as co-president and CEO for 10 years before the company’s acquisition by Ajinomoto. Marquet co-founded Althea Dx, a spin-off of Althea Technologies focusing in precision medicine. She previously held management positions at numerous biotechnology companies, and serves as a Board member and advisor for many others. She has received numerous awards throughout her career as a business leader passionate about entrepreneurship including the Regional Entrepreneur of the Year award in Life Sciences and the Director of the Year award. She holds the honor of being the first woman inducted into the CONNECT Entrepreneur Hall of Fame.



Poonacha Machaiah

Poonacha Machaiah has over 20 years of global experience as a successful entrepreneur and business leader in Fortune 100 companies. He is passionate about conscious leadership and wellbeing and is pursuing his mission of “personal transformation and societal wellbeing” working alongside leading companies and industry thought leaders. Poonacha holds an MBA from the College of William and Mary and a Bachelor of Science in Computer Science and Engineering from the B.M.S. College of Engineering in Bangalore, India.
He has co-founded "Jiyo,", a wellbeing platform that he created alongside internationally Deepak Chopra M.D. and ‘Beyond Performance Sports’, along with a team of global industry leaders who are continually exploring the boundaries of what is possible in sports performance. He is also a co-founder of ‘Deepak Chopra Innerspace’, a revolutionary new technology startup that leverages “grounding” to reducing inflammation in both body and mind to restore whole health and wellbeing, and of the ‘WeightLess Project’, an international movement to address the lifestyle and nutrition-based challenges that plague our global communities.